Italian Lung Cancer Observational Study

Lung Cancer Clinical Trial

— LUCENT  

Official title:

Italian Lung Cancer Observational Study

Clinical Trial Details — Status: Enrolling by invitation

Administrative data

• NCT number: NCT05851755
• Other study ID #: IRRB/04/23
• Status: Enrolling by invitation
• Start date: April 1, 2023
• Est. completion date: March 31, 2028

Study information

• Verified date: April 2023
• Source: The Mediterranean Institute for Transplantation and Advanced Specialized Therapies
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

LUCENT is an observational study focused on malignant pulmonary and tracheo-bronchial disease. It involves a large proportion of reference Italian thoracic surgery centers. The relevance of the study is related to the epidemiology of lung cancer in the world - also known as "Big Killer" - and the high mortality rates both in males and females.

The aim of his prospective study is to collect a large bulk of postoperative patients' outcome data and to produce up-to-date descriptive statistics of patients undergoing surgery for lung cancer. These results will be pivotal to compare the clinical results of all the relevant specialities involved in the care of lung cancer such as medical oncologists and radiation oncologists.

Recruitment information / eligibility

• Status: Enrolling by invitation
• Enrollment: 1000
• Est. completion date: March 31, 2028
• Est. primary completion date: March 31, 2028
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Patients with lung cancer

• informed consent

Exclusion Criteria:

• alcohol or drug abuse

• age < 18

• inability to express consent

Related Conditions & MeSH terms

• Lung Cancer
• Lung Neoplasms

Locations

Country	Name	City	State
Italy	University of L'Aquila	L'Aquila

Sponsors (13)

Lead Sponsor	Collaborator
The Mediterranean Institute for Transplantation and Advanced Specialized Therapies	AUSL Romagna Rimini, Azienda Ospedaliera di Bolzano, Azienda Ospedaliera di Perugia, Azienda Ospedaliero, Universitaria Pisana, Azienda Policlinico Umberto I, Azienda Socio Sanitaria Territoriale di Mantova, European Institute of Oncology, Monaldi Hospital, S. Andrea Hospital, Università degli Studi dell'Aquila, Università degli Studi di Ferrara, University of Milan

Country where clinical trial is conducted

Italy, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Lung cancer surgery outcomes	Benchmarking national outcome data of the treatment of lung cancer	5 years